RecruitingNCT06491186

Pulse Checks Using Femoral Artery B-Mode Ultrasound With Compressibility Assessment

Femoral Artery Ultrasound With Compressibility Assessment as a Method for Pulse Checks in Out-of-Hospital Cardiac Arrest: A Prospective Exploratory Study.


Sponsor

Medical University of Vienna

Enrollment

69 participants

Start Date

May 2, 2024

Study Type

OBSERVATIONAL

Conditions

Summary

The goal of this prospective observational study is to investigate B-mode point-of care ultrasound with arterial compressibility assessment on the femoral artery as a method to determine the presence of a pulse and to compare it with concurrently conducted manual pulse checks.


Eligibility

Min Age: 18 Years

Inclusion Criteria2

  • Out-of-hospital cardiac arrest treated by EMS
  • Minimum age of 18 years

Exclusion Criteria7

  • Pregnancy or suspected pregnancy
  • Disapproval of the treating EMS team
  • Adults under legal guardianship
  • Inability to perform femoral artery doppler ultrasound due to limited access to the patient and possible interference with the treating EMS team
  • Inability to perform femoral artery doppler ultrasound due to injuries or anatomic abnormalities in the femoral region or necessary emergent medical interventions in the femoral region
  • Decision to transfer the patient to the hospital with ongoing CPR for emergent procedures such as extracorporeal CPR before femoral artery doppler ultrasound could be attempted
  • Inability to safely perform femoral artery doppler ultrasound due to environmental hazards

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERPoint of Care Ultrasound

Point-of-care ultrasound will be used to image the femoral vessels and to assess the presence or absence of a pulse and the compressibility of the artery during rhythm checks.


Locations(1)

Emergency Medical Service of Vienna

Vienna, Austria

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06491186


Related Trials